Thorsten Gutjahr

VP, Global Head of Precision Diagnostics Development at AstraZeneca Driving precision medicine to redefine patient care​

Baar, Zug, Switzerland

About

I’m passionate about science, innovation, and delivering meaningful impact for patients. As VP and Global Head of Precision Diagnostics Development at AstraZeneca, Oncology R&D, I'm leading strategy, development, and lifecycle delivery of regulated diagnostics across Oncology and BioPharma. Scientist and executive leader with 70+ approved Companion Diagnostics in US, EU, Japan, and China enabling targeted therapies for patients and faster access. Driving AZ’s Precision Medicine ambition through high-impact diagnostics partnerships, co-development alliances, and CDx regulatory innovation. Excited and ambitious about AI-driven diagnostics to transform patient selection and global access.

Experience

  • AstraZeneca (12 yrs 7 mos)
    • VP, Global Head of Companion Diagnostics and Head of Companion Diagnostics Unit Oncology
      May 2014 - Present · 12 yrs 3 mos

    • Global Head of Companion Diagnostics
      2014 - 2015 · 1 yr

  • F. Hoffmann-La Roche Ltd ()
    • Head of Biomarkers in Diagnostics Division
      Apr 2009 - Apr 2014 · 5 yrs 1 mo

    • Senior Biomarker Experimental Medicine Leader Oncology
      Apr 2002 - Apr 2009 · 7 yrs 1 mo